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Abstract
Background: Schizophrenia is a complex brain disorder with molecular mechanisms that have yet to be
elucidated. Previous studies have suggested that changes in gene expression may play an important role in the
etiology of schizophrenia, and that microRNAs (miRNAs) and transcription factors (TFs) are primary regulators of
this gene expression. So far, several miRNA-TF mediated regulatory modules have been verified. We hypothesized
that miRNAs and TFs might play combinatory regulatory roles for schizophrenia genes and, thus, explored miRNA-
TF regulatory networks in schizophrenia.
Results: We identified 32 feed-forward loops (FFLs) among our compiled schizophrenia-related miRNAs, TFs and
genes. Our evaluation revealed that these observed FFLs were significantly enriched in schizophrenia genes. By
converging the FFLs and mutual feedback loops, we constructed a novel miRNA-TF regulatory network for
schizophrenia. Our analysis revealed EGR3 and hsa-miR-195 were core regulators in this regulatory network. We
next proposed a model highlighting EGR3 and miRNAs involved in signaling pathways and regulatory networks in
the nervous system. Finally, we suggested several single nucleotide polymorphisms (SNPs) located on miRNAs, their
target sites, and TFBSs, which may have an effect in schizophrenia gene regulation.
Conclusions: This study provides many insights on the regulatory mechanisms of genes involved in schizophrenia.
It represents the first investigation of a miRNA-TF regulatory network for a complex disease, as demonstrated in
schizophrenia.
Background
Schizophrenia is a complex, chronic and severe brain
disorder. So far, its pathophysiology and molecular
mechanisms have remained poorly understood [1]. In
the last decade numerous linkage and association stu-
dies, including a few genome-wide association studies
(GWAS), have been performed to identify genetic pre-
dispositions to the disease, but most studies have been
inconclusive. The limited success in the detection of
genetic factors led us to hypothesize that schizophrenia
is likely caused by the altered expression of many genes,
which may individually contribute only a small risk, but
may in aggregate interact at the biological pathway or
gene-network level.
Recently, patterns of differential gene expression have
been identified between schizophrenia case and control
samples [2,3]. MicroRNAs (miRNAs) and transcription
factors (TFs) are main regulators of gene expression.
MiRNAs are short endogenous noncoding RNAs that
mediate post transcriptional regulation and regulate a
wide range of biological processes and diseases [4,5]. In
the nervous system, studies have reported involvement
of miRNAs in brain development, neuronal differentia-
tion, and synaptic plasticity, all processes that have been
implicated in neurological syndromes such as schizo-
phrenia, fragile × syndromes, Parkinson’s disease and
Huntington’s disease [5]. Specifically, 18 miRNAs were
recently found to be differentially expressed in post-
mortem brain samples of schizophrenia patients and
controls [6,7]. Interestingly, a case-control association
study revealed that two single nucleotide polymorphisms
(SNPs) in miRNAs hsa-miR-206 and hsa-miR-198 were
significantly associated with schizophrenia [8]. Further-
more, brain miRNAs affected by a microdeletion synte-
nic to human 22q11.2 were found in mouse models and
human individuals carrying this microdeletion are at
high risk of developing schizophrenia [9]. It has also
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and alters the expression of downstream GABAergic
transcripts in schizophrenia [10]. Most recently, studies
found that a miRNA regulates signaling downstream
from the NMDA receptor, suggesting miRNAs as a new
mechanism for altering brain gene expression in schizo-
phrenia [11,12]. This accumulating data suggests that
miRNAs may play important roles in the expression of
genes linked to schizophrenia.
Transcription factors are essential regulators of gene
expression in all living organisms. A TF regulates tran-
scription of its target gene by specifically binding to the
transcription factor binding site (TFBS) in the gene’s
promoter region. Since expression of an miRNA may be
regulated by a TF [13], TF and miRNA may reciprocally
regulate one another to form feedback loops, or alterna-
tively, both TF and miRNA may regulate their target
genes and form feed-forward loops (FFLs). Two recent
studies explored hundreds of potential miRNA-mediated
feedback and feed-forward loops at the genome level in
mammals and found some interesting regulatory motifs
[14,15]. Besides, Martinez et al.[ 1 6 ]c o m b i n e de x p e r i -
mental and computational methods and identified 23
miRNA-TF composite feedback loops in C. elegans. Sev-
eral feedback loops and FFLs have been experimentally
verified in mammals, such as feedback loops between
ZEB1/SIP1 and miR-200 family in embryological devel-
opment, E2Fs and miR-17/20 in cellular apoptosis,
PITX3 and miR-133b in midbrain dopamine neurons,
and a FFL E2Fs-Myc-miR-17/20 [17-19]. These studies
were performed at the whole genome level by a compu-
tational approach or for specific FFLs by experimental
validation, rather than a comprehensive miRNA-
mediated network analysis for a specific complex disease
or tissue.
In this study, we explored miRNA-TF regulatory net-
works in schizophrenia. Among schizophrenia candidate
genes (SZGenes), we identified the potential targets of
TFs and schizophrenia related miRNAs. These datasets
and their regulations were used for miRNA-mediated
f e e d b a c ka n df e e d - f o r w a r dl o o pa n a l y s i s .W er e v e a l e d
some schizophrenia related miRNA-TF regulatory mod-
ules and constructed a converged miRNA-TF regulatory
network in which EGR3 and hsa-miR-195 served as core
regulators. By combining miRNA-TF network analysis
and literature survey, we proposed a pathway model
highlighting EGR3 and miRNAs involving in the signal
transduction and regulatory pathways in schizophrenia.
Results
miRNAs and TFBSs
Our goal is to explore miRNA and TF regulation in
schizophrenia genes. Figure 1 provides an overview of
miRNA and TF mediated regulatory network
construction. We first compiled a list of 20 experimen-
tally verified schizophrenia related miRNAs (SZmiR-
NAs), which matched 21m a t u r em i R N A sa n d2 9
miRNA precursors (Table 1). Most of the 29 SZmiRNAs
are conserved in vertebrate genomes and 9 are even
conserved in Drosophila. Only one (hsa-miR-198) is pri-
mate-specific and two (hsa-miR-195 and hsa-miR-206)
are mammal-specific. Sixteen SZmiRNAs (55%) were
found in miRNA clusters. For comparison, we also col-
lected and curated 87 brain expressed and 79 non-brain
expressed mature miRNAs, which corresponded to 105
and 94 miRNA precursors, respectively (see Additional
file 1).
We predicted miRNA targets in SZGenes by parsing
TargetScan prediction results. Among the 160 SZGenes,
61 were potential targets of our complied 29 SZmiR-
NAs. Figure 2 displays these miRNA and target pairs.
Among the 61 target genes, the top three genes targeted
by the largest number of SZmiRNAs were EGR3,
DPYSL2 and CNR1, which were targeted by 15, 13 and
11 SZmiRNAs, respectively. Among the 29 SZmiRNAs,
the miRNAs targeting the largest number of SZGenes
were hsa-miR-198, miRNAs in miR-30 family and hsa-
miR-195, which targeted 23, 14 and 11 genes, respec-
tively (see Additional file 2: Table S1). Hsa-miR-198 had
the largest number of targets because it is a primate-
specific miRNA and the predicted target sites may not
be conserved with a high false positive rate.
To test whether we observed more SZmiRNA targets
in the 160 SZGenes, we ran a permutation to count the
number of targets of each SZmiRNA in 160 randomly
selected genes, and repeated this process 10,000 times.
Most (25 of 29, 86.2%) of SZmiRNAs had a significantly
larger number of targets in SZGenes than randomly
selected genes (t-test, p-value < 0.001), while hsa-miR-
206 had fewer targets in SZGenes and the difference for
3 miRNAs in hsa-miR-7 family was not significant (see
Additional file 2: Fig. S1).
Using stringent criteria (Z score >2.33 in UCSC Gen-
ome Browser) and conservation among the human,
mouse and rat genomes, we obtained 517 TFBSs in the
promoter regions of 115 of the 160 SZGenes and 184
TFBSs in the promoter regions of 18 of the 29 SZmiR-
N A s .A m o n gt h e1 1 5S Z G e n e s ,7 9( 6 8 . 7 % )h a df e w e r
than 5 TFBSs and 10 (8.7%) had more than 10 TFBSs.
Among the SZmiRNAs, hsa-miR-212 and hsa-miR-195
had more than 20 TFBSs (see Additional file 2: Fig. S2).
These observations seemed to reflect a complex regula-
tion of schizophrenia related genes, TFBSs and miRNAs.
Feed-forward loops (FFLs) in schizophrenia
We obtained 32 FFLs when we combined the regulatory
relationship of SZGenes, SZmiRNAs and TFBSs
(Table 2). We performed following two tests to evaluate
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First, we compared the FFLs obtained from SZmiRNAs
with those from brain miRNAs or non-brain miRNAs
and then evaluated the significance by Fisher’se x a c t
test. The difference was highly significant in the com-
p a r i s o no fF F L sb yS Z m i R N A sv e r s u sn o n - b r a i nm i R -
NAs (p =1 . 8 0×1 0
-5)a n ds i g n i f i c a n tb yS Z m i R N A s
versus brain miRNAs (p = 0.02) using the same
SZGenes (Table 3). To increase the confidence, we did
similar FFL analysis using three other schizophrenia
candidate gene lists (see Methods). When we compared
SZmiRNAs with non-brain miRNAs, the p-value was
always highly significant, indicating that we observed
more FFLs by SZmiRNAs than by non-brain miRNAs
(Table 3). We noticed that the p-values in the compari-
son between SZmiRNAs and brain miRNAs were
slightly significant or even insignificant. This likely
represents some brain miRNAs in our data set that may
be schizophrenia related but that have not yet been
reported.
Secondly, we ran 10,000 random simulations (see
Methods). In each run, since there were 209 miRNA
target pairs between SZmiRNAs and SZGenes, we ran-
domly selected 209 miRNA target pairs out of all target
pairs of the 29 SZmiRNAs and calculated the number of
FFLs among TFBSs, SZmiRNAs and those randomly
selected target genes. We calculated a p value = 0.0009,
indicating that our observed FFLs differed significantly
from chance.
miRNA and TF regulatory network in schizophrenia
TF and miRNA may regulate one another and form a
composite feedback loop. We identified 14 SZmiRNA-
TF mutual regulatory loops (pairs). Twelve of these had
at least one TF or miRNA in the TF-SZmiRNA-SZGene
FFLs and 5 pairs had all components included in the
Table 1 Location and conservation information of schizophrenia related miRNAs
miRNA Location (Chr: start-end [strand]) Host gene
a Taxonomy conservation
b
hsa-let-7g 3: 52277334-52277417 [-] WDR82 V
hsa-miR-106b 7: 99529552-99529633 [-] MCM7 V
hsa-miR-181b hsa-miR-181b-1 1: 197094625-197094734 [-] Intergenic V
hsa-miR-181b-2 9: 126495810-126495898 [+] NR6A1 (antisense) V
hsa-miR-195 17: 6861658-6861744 [-] Intergenic M
hsa-miR-198 3: 121597205-121597266 [-] FSTL1 (3’UTR) P
hsa-miR-206 6: 52117106-52117191 [+] Intergenic M
hsa-miR-20b X: 133131505-133131573 [-] Intergenic V
hsa-miR-212 17: 1900315-1900424 [-] Intergenic V
hsa-miR-24 hsa-miR-24-1 9: 96888124-96888191 [+] C9orf3 V
hsa-miR-24-2 19: 13808101-13808173 [-] Intergenic V
hsa-miR-26b 2: 218975613-218975689 [+] CTDSP1 V
hsa-miR-29a 7: 130212046-130212109 [-] AP4M1 (antisense) V
hsa-miR-29b hsa-miR-29b-1 7: 130212758-130212838 [-] AP4M1 (antisense) V
hsa-miR-29b-2 1: 206042411-206042491 [-] Intergenic V
hsa-miR-29c 1: 206041820-206041907 [-] Intergenic V
hsa-miR-30a 6: 72169975-72170045 [-] C6orf155 V
hsa-miR-30b 8: 135881945-135882032 [-] Intergenic V
hsa-miR-30d 8: 135886301-135886370 [-] Intergenic V
hsa-miR-30e 1: 40992614-40992705 [+] NFYC V
hsa-miR-7 hsa-miR-7-1 9: 85774483-85774592 [-] HNRNPK A
hsa-miR-7-2 15: 86956060-86956169 [+] Intergenic A
hsa-miR-7-3 19: 4721682-4721791 [+] C19orf30 A
hsa-miR-9 hsa-miR-9-1 1: 154656757-154656845 [-] C1orf61 A
hsa-miR-9-2 5: 87998427-87998513 [-] Intergenic A
hsa-miR-9-3 15: 87712252-87712341 [+] Intergenic A
hsa-miR-92a hsa-miR-92a-1 13: 90801569-90801646 [+] Intergenic A
hsa-miR-92a-2 X: 133131234-133131308 [-] Intergenic A
hsa-miR-92b 1: 153431592-153431687 [+] Intergenic A
aAntisense: miRNA and its host gene are on opposite strand. 3’UTR: miRNA locating on the 3’UTR of its host gene. The remaining miRNAs are in the intron of
their host genes.
bTaxonomy conservation: P: primates (human, chimp, rhesus monkey); M: mammals (human, mouse, rat, dog); V: vertebrates (human, mouse, rat, dog, chicken,
frog, fish); A: animals (human, mouse, chicken, fish, fly).
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12 FFL-related SZmiRNA-TF loops with TF-SZmiRNA-
SZGene FFLs and constructed a miRNA-TF regulatory
network for schizophrenia. It included 12 SZmiRNAs,
16 SZGenes, 29 TFs and 110 links (edges) between
these molecules (nodes) (Figure 3). Among these 16
SZGenes, several (DRD2, GRIN1, GRM7 and GAD1)a r e
related to three neurochemical hypotheses in the mole-
cular mechanisms of schizophrenia, i.e., the dopamine,
glutamatergic and GABAergic hypotheses [1]. Three TFs
(ESR1, MYB and TFAP2A) in this network had associa-
tion information in the SchizophreniaGene database
[20] but only the ESR1 gene had a positive association
study [21]. Moreover, there were 3 pairs of regulation
(hsa-miR-195 represses BDNF gene, TF REST regulates
GAD1 gene, and TF CREB1 regulates NR4A2 gene) that
had been previously experimentally verified [10] or
annotated in the Ingenuity Knowledge Base [22].
Subnetworks for core genes in the miRNA-TF regulatory
network
There were 5 core genes (EGR3, hsa-miR-195, hsa-miR-
20b, hsa-miR-9-3 and GRM7) in the miRNA-TF regula-
tory network (Figure 3) according to the definition in
the Methods section. We extracted subnetworks for
these 5 core genes by including the core genes and their
directly linked molecules in the miRNA-TF regulatory
network (see Additional file 2: Fig. S3). In this subnet-
work analysis, EGR3 stood out as a promising gene and
regulator. As a gene, it is regulated by 5 TFs and 4
SZmiRNAs, while in its capacity as a TF, it regulates 3
SZGenes and 3 SZmiRNAs. EGR3 i st h eo n l yg e n ei n
the network that links to all 4 of the other core genes.
Among the 3 core miRNAs (hsa-miR-195, hsa-miR-
20b and hsa-miR-9-3), hsa-miR-195 seems most promis-
ing. It regulates 6 of the 16 SZGenes in the network,
while it is also regulated by 6 TFs (Figure 3, see Addi-
tional file 2: Fig. S3B). We examined the predicted tar-
gets of these 3 miRNAs on all human genes and found
734, 725, and 826 predicted targets, respectively. We
next examined the enriched pathways of these predicted
targets of the 3 core miRNAs using the Ingenuity Path-
way Analysis (IPA) tool. Interestingly, we found many
neuron or schizophrenia related pathways, such as axo-
nal guidance signaling and reelin signaling in neurons
(Table 4). There were two enriched pathways shared by
the targets of these 3 core miRNAs: axonal guidance sig-
naling and Ephrin receptor signaling. Axon guidance is
one of the critical steps in the proper formation of a
neuronal network [23], and Ephrin/Ephrin receptor sig-
naling is one of the bidirectional signaling systems
implicated in the control of axon guidance and synapse
formation in many neural systems [24]. This analysis
suggests that these 3 core miRNAs may have important
regulatory roles in the neuronal network. Finally, we
examined the enriched GO terms of these predicted tar-
gets. Interestingly, among the enriched GO terms were
several related to regulation and neurodevelopment such
as “transcription regulation”, “neuron differentiation”
and “neurogenesis” (see Additional file 2: Table S3).
Figure 1 An overview of miRNAs, TFBSs/TFs and their regulatory network in schizophrenia. SZ: schizophrenia; FFL: feed-forward loop.
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SNPs on miRNA target sites and TFBSs have been asso-
ciated with many complex diseases [4,25,26]. So far,
most of the SNPs associated with schizophrenia have
not been in exonic regions [20]. Thus, it is important to
examine SNPs in these schizophrenia related miRNA
genes and their target sites and TFBSs. We identified 7
SNPs on the SZmiRNA target sites of 7 SZGenes, 14
SNPs on TFBSs of 13 SZGenes and 5 SNPs on TFBSs
of 5 SZmiRNAs. Moreover, we found 4 SNPs in pre-
SZmiRNAs and 18 SNPs in the expanded regions (100
bp each side) of pre-SZmiRNAs including one SNP
(rs41283391) located 46 bp upstream of hsa-miR-195
pre-miRNA (see Additional file 3).
There were two publicly available GWA studies
(CATIE and GAIN) for schizophrenia, neither of which
has yet been successful in identifying significant gen-
ome-level markers [27]. Surprisingly, all of these SNPs
except one (rs1700 in hsa-miR-198), were not included
in either GWAS marker set. We found two potential
regulatory SNPs in GRM7,o n eo ft h ef i v ec o r e
genes. These two SNPs were located on TFBS
(V$AHRARNT_01, SNP rs62237229) and miRNA
target site (hsa-miR-20b, SNP rs56173829). Both
V$AHRARNT_01 and hsa-miR-20b were included in
our FFLs. Our literature search revealed that these SNPs
and sites have not been studied for schizophrenia.
Further experimental verification is warranted.
Online access of miRNAs and their targets in
schizophrenia genes
We deposited all miRNAs complied in this study and
their potential targets in schizophrenia genes into Schi-
zophrenia Gene Resource (SZGR), a comprehensive
online resource including genetic and biological data for
schizophrenia genes [28]. SZGR deposits genetic data
Figure 2 Schizophrenia candidate genes targeted by schizophrenia related miRNAs. To simply the figure, miRNA family names are used
for their precursors.
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linkage scans, gene expression, literature, GO annota-
tions, gene networks, pathways, and miRNAs and their
target sites. Moreover, SZGR provides online tools for
data browsing and searching, data integration, custom
gene ranking, and graphical presentation.
Discussion
Potential regulatory networks in schizophrenia
We performed an exploratory miRNA-TF mediated reg-
ulatory network analysis, identifying some promising
FFLs and mutual feedback loops in schizophrenia. In
the converged network, we identified 5 core genes
including EGR3 and hsa-miR-195 that likely play impor-
tant regulatory roles. The network also includes some
well-studied schizophrenia candidate genes (e.g., BDNF,
DRD2, GRIN1 and GAD1). Although this investigation
started from experimentally verified schizophrenia-
related miRNAs, miRNA-TF-gene regulations, and a set
of schizophrenia candidate genes prioritized by multiple
lines of genetic evidence, most of the miRNA targets
and TFBSs used in this study are putative and not
error-free. At present, miRNAs have not been well
tested for association with schizophrenia. The number
of schizophrenia related miRNAs is expected to be
greater than what we compiled. However, our analysis
and subsequent permutation tests indicated that our
regulatory network is nonrandom in the whole molecu-
lar network. The identified network modules provide
potential targets for follow-up experimental verification,
and provide important insights into the etiology of schi-
zophrenia. We discuss some potential pathways below.
EGR3 encodes a zinc finger transcription factor and
plays important roles in cellular growth, environmental
stimuli, muscle-spindle development and neuronal
development [29]. In neuronal development, EGR3 is
Table 2 FFLs among TFBSs, SZmiRNAs and schizophrenia genes (SZGenes)
No. SZGene miRNA TFBS matrix Matrix consensus TF symbol
1 ARVCF hsa-miR-29b-2 V$TCF11MAFG_01 ATGACTCAGCANTTNNG NFE2L1, MAFG
2 ARVCF hsa-miR-29c V$TCF11MAFG_01 ATGACTCAGCANTTNNG NFE2L1, MAFG
3 BDNF hsa-miR-195 V$NFKB_C GGGACTTTCCA NFKB1, NFKB2
4 DRD2 hsa-miR-9-3 V$RP58_01 AACATCTGGA ZNF238
5 EGR3 hsa-miR-181b-1 V$IK3_01 TNYTGGGAATACC IKZF1
6 EGR3 hsa-miR-20b V$NGFIC_01 TGCGTRGGYGK EGR1, EGR2, EGR3, EGR4
7 EGR3 hsa-miR-9-1 V$MZF1_02 KNNNKAGGGGNAA MZF1
8 EGR3 hsa-miR-9-1 V$OCT_C CTNATTTGCATAY POU2F1; POU2F2
9 EGR3 hsa-miR-9-3 V$CREBP1_Q2 VGTGACGTMACN CREB1, ATF2
10 GAD1 hsa-miR-9-2 V$OLF1_01 CDABTCCCYAGRGARBNKG EBF1
11 GAD1 hsa-miR-9-3 V$NRSF_01 TTCAGCACCACGGACAGMGCC REST
12 GRIN1 hsa-miR-195 V$EGR1_01, V$NGFIC_01 TGCGTRGGYGK EGR1, EGR2, EGR3, EGR4
13 GRM7 hsa-miR-195 V$AHRARNT_01 KNNKNNTYGCGTGCMS AHR, ARNT
14 GRM7 hsa-miR-195 V$NGFIC_01 TGCGTRGGYGK EGR1, EGR2, EGR3, EGR4
15 GRM7 hsa-miR-20b V$NGFIC_01 TGCGTRGGYGK EGR1, EGR2, EGR3, EGR4
16 GRM7 hsa-miR-20b V$TAL1BETAE47_01 AACAGATGKT TCF3, TAL1
17 GRM7 hsa-miR-92a-2 V$NGFIC_01 TGCGTRGGYGK EGR1, EGR2, EGR3, EGR4
18 GRM7 hsa-miR-92a-2 V$TAL1BETAE47_01 AACAGATGKT TCF3, TAL1
19 HTR4 hsa-miR-195 V$AHRARNT_01 KNNKNNTYGCGTGCMS AHR, ARNT
20 HTR4 hsa-miR-195 V$GCNF_01 TCAAGKTCAAGKTCA NR6A1
21 MTHFR hsa-miR-24-2 V$AHRARNT_02 KNNKNNTYGCGTGCMS AHR, ARNT
22 NEUROG1 hsa-miR-20b V$POU6F1_01 GCATAAWTTAT POU6F1
23 NR4A2 hsa-miR-20b V$PAX4_03 YCACCCB PAX4
24 NR4A2 hsa-miR-212 V$BACH2_01 SRTGAGTCANC BACH2
25 NR4A2 hsa-miR-212 V$CEBP_C GWVTKNKGYAAKNSAYA CEBPA
26 NR4A2 hsa-miR-212 V$CREB_01, V$CREBP1CJUN_01, V$CREBP1_Q2 TGACGTMA CREB1, ATF2
27 NR4A2 hsa-miR-212 V$FREAC3_01 GTAAATAAACA FOXC1
28 NTNG1 hsa-miR-9-3 V$PAX5_02 RRMSWGANWYCTNRAGCGKRACSRYNSM PAX5
29 PDLIM5 hsa-miR-195 V$AHRARNT_01 KNNKNNTYGCGTGCMS AHR, ARNT
30 RTN4 hsa-miR-212 V$BACH1_01, V$BACH2_01 SRTGAGTCA BACH1, BACH2
31 TSNAX hsa-miR-9-1 V$OCT_C CTNATTTGCATAY POU2F1, POU2F2
32 YWHAH hsa-miR-195 V$EGR1_01 TGCGTRGGYGK EGR1, EGR2, EGR3, EGR4
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branching, sympathetic target tissue innervation and
function, and hippocampus-dependent learning and
memory processing [30,31]. EGR3 indirectly modulates
synaptic plasticity through its regulation of the ARC
gene, a synaptic activity-induced effector molecule [32].
In developing neurons and epilepsy, BDNF is the endo-
genous signal that induces EGR3 expression via a PKC/
MAPK-dependent pathway, and then EGR3 up-regulates
the expression of GABRA4 by binding its promoter
[33,34]. EGR3 is required in mediating the response to
stress and novelty [35]. EGR3 has been reported to be
associated with schizophrenia in both case-control and
family-based studies and its expression has been shown
to be decreased in schizophrenia patients [36,37]. Mice
lacking EGR3 and schizophrenia patients display a simi-
lar decreased susceptibility to the side effects of antipsy-
chotic medications [38]. These studies consistently
suggest an important role for EGR3 in neuron activity
and schizophrenia.
Moreover, EGR3 is a downstream gene of many sig-
naling pathways including pathways triggered by NGF,
BDNF and NRG1 [30,34,39,40], of which BDNF and
NRG1 are schizophrenia susceptibility genes. Both EGR1
and EGR2 are induced by BDNF signaling in primary
cortical neurons [41] and EGR3 has been proved to be a
target gene of EGR1 [42]. EGR3 and EGR1 directly reg-
ulate the expression of NGFR (p75NTR) [43], a receptor
of all neurotrophins, including NGF and BDNF. Inter-
estingly, NGFR is involved in the regulation of axonal
elongation [44] and EGR3 shares a similar function [30].
EGR3 is regulated by the calcium-responsive protein
phosphatase calcineurin [45], which might be triggered
by a calcium influx through NMDARs [46], whose acti-
vation also induces EGR3 mRNA expression [47].
PPP3CC (encoding calcineurin catalytic g subunit) is
located very close to EGR3 on chromosome 8 and was
reported to be associated with schizophrenia [37,48].
Furthermore, the calcineurin/NFAT signaling pathway is
required for neuronal development and axon growth,
but it has little or no effect in neuron survival [49,50].
Interestingly, EGR3 is also required for normal axon
extension and branching, but not for neuron survival
[30]. Neurotrophins (NGF and BDNF) stimulate NFAT
nuclear translocation and activation of NFAT-dependent
transcription in cortical neurons [50]. It has been pro-
p o s e dt h a ts o m eu n k n o w nf a c t o r si n v o l v e di nc a l c i -
neurin/NFAT signaling induce axon growth [49,50].
Based on these literature surveys and our miRNA-
mediated regulatory network analysis, we propose that
EGRs, especially EGR3, are key factors regulated by cal-
cineurin/NFAT signaling in neuronal development.
Moreover, in the immune system, NFAT directly trans-
activates EGR3 and EGR2, then activates the expression
of FasL to trigger cell apoptosis [51].
The above discussion led us to propose a model of the
involvement of EGR3 and miRNAs in signaling path-
ways and regulatory networks within nervous system
and schizophrenia (Figure 4). We inferred that EGR
genes, especially EGR3, are downstream of BDNF,
NRG1,a n dNGF via two pathways: MAPK-dependent
signaling pathway and calcium-dependent calcineurin/
NFAT signaling pathway. EGR3 expression is triggered
by these two pathways after signal stimulation. Then,
EGR3 activates its target protein-coding genes (e.g.,
ARC, GABRA4 and NGFR) and miRNAs (e.g., hsa-miR-
195 and hsa-miR-20b). These target genes subsequently
trigger downstream genes and pathways, inducing pro-
cesses such as synaptic plasticity, axon extension,
GABAergic and regulating expression of BDNF and
DRD2.
Hsa-miR-195 might prove a promising miRNA in
schizophrenia and nervous system
Hsa-miR-195 is a core miRNA potentially targeted by 6
TFs and also targeting 6 SZGenes in our network. It
was reported significantly down-regulated in the pre-
frontal cortex of schizophrenia patients [6]. So far, it has
been the only miRNA whose regulation of schizophrenia
genes has been verified by experimental evidence. It reg-
ulates BDNF, altering the expression of downstream
GABAergic transcripts (NPY, SST and PV)i ns c h i z o -
phrenia patients [10]. Note that BDNF also affects
GABAergic system as a mediator of EGR3-induced
GABRA4 regulation in developing neurons [34]. In our
miRNA-mediated FFLs, EGR3 potentially regulates hsa-
miR-195. Thus, hsa-miR-195, BDNF and EGR3 form a
critical feedback regulatory loop (Figure 4). The pre-
dicted targets of hsa-miR-195 are enriched in neuron
related pathways, such as axonal guidance signaling,
Table 3 Statistics of FFLs identified by miRNAs among four schizophrenia gene lists
miRNA dataset No. of miRNAs 160 SZGenes 75 SZGenes 124 SZGenes 270 SZGenes
FFLs p-value FFLs p-value FFLs p-value FFLs p-value
SZmiRNAs 29 32 12 27 38
Brain miRNAs 105 55 0.020 26 0.204 49 0.035 87 0.120
Non-brain miRNAs 94 24 1.80 × 10
-5 11 9.86 × 10
-3 20 4.79 × 10
-5 27 2.97 × 10
-7
P-value was calculated by Fisher’s exact test between SZmiRNAs and brain miRNAs or between SZmiRNAs and non-brain miRNAs.
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Page 7 of 14reelin signaling in neurons, long term synaptic potentia-
tion and Ephrin receptor signaling pathways (Table 4).
In combination, the evidence above suggests that hsa-
miR-195 might be a key miRNA in schizophrenia as
well as nervous system.
Potential utilities of FFLs and miRNA-TF composite
feedback loops
FFL is an important regulatory motif and has been
found in organisms such as Escherichia coli,y e a s ta n d
human [52]. A traditional FFL is composed of two TFs
and one target gene in gene expression regulation.
Because miRNAs play key regulatory functions in gene
expression, a FFL consisting of a TF, miRNA and a tar-
get gene is likely a powerful tool to investigate regula-
tory mechanisms of diseases at both the transcriptional
and translational levels. It has been estimated that there
are several thousands of human genes under this combi-
natory TF-miRNA regulation [14]. At present, only a
few FFLs have been experimentally verified. Some
Figure 3 A miRNA and TF mediated regulatory network in schizophrenia. Red: schizophrenia related miRNAs; green: schizophrenia
candidate genes; blue: TFs. Three thick lines denote regulations with experimental evidence.
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Page 8 of 14examples include E2Fs-Myc-miR-17/20 [19], E2F-miR-
106b/93/25-CDK inhibitors [53] and PKC-MAPK-miR-
15a [54]. A miRNA-TF composite feedback loop is a
direct regulation motif. Some experimental examples are
ZEB1/SIP1 and the miR-200 family in embryologic
development and Pitx3 and miR-133b in neuron devel-
opment [17,18]. In our miRNA-mediated network in
schizophrenia, we found an interesting miRNA-TF loop,
the miR181-ESR1 loop. ESR1 is the only TF in our net-
work whose gene has positive association result for schi-
zophrenia [21]. Some SNPs in ESR1 were also found
significantly associated with schizophrenia in our geno-
typing project (unpublished data). Additionally, Inoue et
al. [55] suggested EGR3 being a target of ESR1 in breast
Table 4 Pathways enriched among the targets of 3 core miRNAs
miRNA Enriched pathway of miRNA targets
a p-value
hsa-miR-195 TGF-b signaling 3.98 × 10
-5
Axonal guidance signaling 1.35 × 10
-4
Wnt/b-catenin signaling 2.04 × 10
-4
BMP signaling pathway 3.47 × 10
-4
FGF signaling 7.59 × 10
-4
Protein ubiquitination pathway 9.12 × 10
-4
CDK5 signaling 1.55 × 10
-3
PTEN signaling 1.86 × 10
-3
Amyloid processing 2.00 × 10
-3
B cell receptor signaling 3.72 × 10
-3
Inositol phosphate metabolism 4.57 × 10
-3
PI3K/AKT signaling 4.79 × 10
-3
Reelin signaling in neurons 4.79 × 10
-3
Synaptic long term potentiation 7.08 × 10
-3
PPARa/RXRa activation 7.59 × 10
-3
Ephrin receptor signaling 7.59 × 10
-3
Insulin receptor signaling 9.12 × 10
-3
hsa-miR-20b Cell cycle: G1/S checkpoint regulation 1.10 × 10
-4
Reelin signaling in neurons 2.75 × 10
-4
B cell receptor signaling 3.55 × 10
-4
Axonal guidance signaling 4.17 × 10
-4
TGF-b signaling 5.50 × 10
-4
p53 signaling 1.12 × 10
-3
Semaphorin signaling in neurons 1.29 × 10
-3
SAPK/JNK signaling 1.35 × 10
-3
Hypoxia signaling in the cardiovascular system 2.04 × 10
-3
Wnt/b-catenin signaling 3.24 × 10
-3
PI3K/AKT signaling 3.89 × 10
-3
CNTF signaling 3.98 × 10
-3
Cell cycle: G2/M DNA damage checkpoint regulation 5.75 × 10
-3
Circadian rhythm signaling 6.03 × 10
-3
Ephrin receptor signaling 6.03 × 10
-3
Factors promoting cardiogenesis in vertebrates 7.41 × 10
-3
FGF signaling 7.41 × 10
-3
HIF1a signaling 7.59 × 10
-3
ERK/MAPK signaling 8.71 × 10
-3
hsa-miR-9-3 ERK/MAPK signaling 1.58 × 10
-4
Regulation of actin-based motility by Rho 2.88 × 10
-3
Clathrin-mediated endocytosis 3.72 × 10
-3
Axonal guidance signaling 3.89 × 10
-3
Ephrin receptor signaling 4.17 × 10
-3
Fcg receptor-mediated phagocytosis in macrophages and monocytes 6.31 × 10
-3
aPathways in italic are related to nervous system or schizophrenia.
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Page 9 of 14cancer cells. Since EGR3 i sac o r eg e n ei no u rm i R N A -
mediated schizophrenia network, this provides another
link for ESR1 to schizophrenia.
Conclusion
We compiled schizophrenia related miRNAs to predict
SZmiRNA-TF-SZGene FFLs and found significantly
more SZmiRNA-related FFLs in schizophrenia candidate
genes. This is the first study of miRNA-TF regulatory
networks in schizophrenia. We revealed that EGR3 and
hsa-miR-195 are critical in the schizophrenia regulatory
network. EGR3 is at the convergence of several signaling
pathways, miRNA regulatory networks, adaptation to
stress, and genetic susceptibility to schizophrenia.
Figure 4 Model of EGR3 and miRNAs involving in signaling pathways and regulatory networks in schizophrenia and nervous system.
Binding of neurotrophins (BDNF or NGF) to Trk receptors activates multiple signaling pathways, including Ras/MAPK cascade, PKC, PI3K/AKT, and
IP3/calcium signaling [72,73]. Stimulation of NRG1 activates MAPK and PI3K/AKT pathways [74]. These signal transductions trigger activation of
several TFs such as CREB, CBP, EGR1 and EGR3, which subsequently activate their target genes (e.g., EGR3, BCL2 and NPY). Calcium influx through
NMDARs activates calcineurin/NFAT signaling pathway, then activates target genes such as EGR3 [46,49]. EGR3 regulates its target genes (e.g.,
GABRA4, ARC and NGFR) and miRNAs (e.g., hsa-miR-195 and hsa-miR-20b).
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native and, perhaps, an effective approach for studying
the regulatory mechanisms of genes involved in
schizophrenia.
Methods
Schizophrenia, brain expressed, and non-brain expressed
miRNAs
We compiled schizophrenia related miRNAs (SZmiR-
NAs) from three studies: (1) 16 miRNAs differentially
expressed in prefrontal cortex of schizophrenia patients
from controls [6]; (2) 2 miRNAs differentially expressed
in postmortem cortical tissues of schizophrenia patients
from controls [7]; and (3) 2 miRNAs in which 2 SNPs
w e r ef o u n da s s o c i a t e dw i t hs chizophrenia in case/con-
trol samples [8]. For comparison, we compiled two con-
trol miRNA datasets: miRNAs expressed in brain (brain
miRNAs) and non-brain tissues (non-brain miRNAs).
Brain miRNAs were collected from miRNA microarray
expression studies and a miRNA regulation survey study
[7,56,57]. Non-brain miRNAs were collected from two
large-scale miRNA expression atlas studies [58,59]. After
we manually checked these miRNAs, we removed
SZmiRNAs from brain miRNAs and, similarly, brain
miRNAs from non-brain miRNAs to avoid redundancy.
We obtained information of genomic locations, host
genes and conservation among species of these miRNAs
from miRBase (Release 11.0, genome assembly: NCBI36)
[60].
Schizophrenia candidate genes
We used a list of 160 schizophrenia candidate genes
(SZGenes) prioritized by a multi-dimensional evidence-
based prioritization approach [61]. These genes were
selected based on integrative evidence from linkage,
association, gene expression and literature search. Our
follow up evaluation using independent GWAS p-values
and gene expression features suggested these genes were
promising [61]. Additionally, we compiled three other
SZGene lists: (1) 270 genes having at least one positive
association result in the SchizophreniaGene database
(accessed in April 2008) [20], (2) 124 genes having at
least two positive results in the SchizophreniaGene data-
base, and (3) 75 SZGenes selected by a combined odds
ratio method from association studies [62].
Target prediction of miRNAs and transcription factors
Among many miRNA target prediction programs, Tar-
getScan had the best performance based on two large
scale miRNA induced protein synthesis studies [63,64].
We retrieved all the miRNA target prediction results
from the TargetScan server (version 4.2, April 2008)
[65] and then extracted the miRNA and target gene
pairs by the corresponding miRNA lists (e.g.,
SZmiRNAs) and genes (e.g., SZGenes). Except one
miRNA that is conserved only in primates (hsa-miR-
198, Table 1), we required the miRNA target sites to be
conserved in mammals. Although SZGenes tend to be
longer [61], the length of the 3’ untranslated regions
(UTRs) in which target sites were predicted, was not
found significantly different between the SZGenes and
the other human genes (Wilcoxon test, p =0 . 0 9 ) .T o
examine whether SZmiRNAs have more miRNA targets
in SZGenes than in non-SZGenes, we randomly selected
the same number of genes from the human protein-cod-
ing genes and then counted the number of targets of
each SZmiRNA for the random genes. We repeated this
randomness analysis 10,000 times. Then, we used one
sample t-test to test the significance.
miRNAs clustered in a genomic region are preferen-
tially co-expressed and miRNAs in gene region are
usually co-expressed with their host genes, presumably
d u et ob e i n gp a r to ft h es a m et r a n s c r i p t i o nu n i t
[58,59,66,67]. After comparing the miRNA cluster
r e s u l t so f3k b ,5k b ,a n d1 0k b ,w eu s e da5k bm a x i -
mum inter-miRNA distance as the miRNA cluster cri-
teria, which is the same as in Xu and Wong [68].
Putative promoter regions of intergenic miRNAs were
estimated up to several kb upstream from the miRNA
precursors [13,69]. Here, we used 5 kb upstream of the
host gene, miRNA precursor or miRNA cluster as the
putative promoter region for miRNA in a genic region,
intergenic region or miRNA cluster, respectively. Similar
FFL results were found when we set a 1 kb promoter
region (data not shown).
Because TFBS is always short, i.e., a 6-8 bp core
sequence, prediction of TFBS in a single species may
have a much higher false positive rate than that based
on conservation across multiple species. We retrieved
predicted TFBS information from the UCSC genome
browser (hg18 genome assembly) and required TFBSs to
be conserved among humans, mice and rats. To further
reduce the false positive prediction, we used Z score of
2.33 as a cutoff for high quality TFBSs. A TFBS was
considered associated with a target gene when it was in
the gene’s promoter region and its Z score was >2.33.
Feed-forward loops (FFLs) and statistics tests
We analyzed FFLs for TFBSs, miRNAs and schizophre-
nia genes according to the procedure in Figure 1. Some
TFBSs might overlap on their locations, could be bound
by the same TF, or could be combined due to similar
sequences. We manually merged those TFBSs to reduce
redundancy.
Two methods were used to evaluate if the FFLs
observed in the set of TFBSs, SZmiRNAs and SZGenes
were significantly enriched from genome background.
First, for the same SZGenes, we used Fisher’se x a c tt e s t
Guo et al. BMC Systems Biology 2010, 4:10
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those from brain miRNAs or non-brain miRNAs. Sec-
ond, we ran randomization processes using the method
in Shalgi et al [14]. In each run, we extracted the same
number of random miRNA target pairs out of all pre-
dicted target pairs of the SZmiRNAs and identified
TFBSs in the promoter of these random miRNA target
genes, then calculated the number of FFLs. We repeated
this 10,000 times, and set the p-value as the proportion
of the random results that had no less than the number
of FFLs observed in the set of SZmiRNAs and SZGenes.
Network and pathway analysis
W eu s e dt h eC o r eA n a l y s i st o o li nt h eI n g e n u i t yP a t h -
way Analysis (IPA) system [22] to analyze networks and
pathways for a set of genes. We set p-value < 0.01 as
the cutoff for enriched significant pathways identified by
IPA. Networks were presented with Cytoscape software
(version 2.6.0) [70]. In the miRNA-TF mediated net-
w o r k ,w h e nas c h i z o p h r e n i ag e n ew a sr e g u l a t e db ya t
least 3 TFs and at least 3 miRNAs, we defined it a core
gene (hub gene). Similarly, when a miRNA regulated at
least 3 SZGenes and was also regulated by at least 3
TFs, we defined it a core miRNA. Enriched GO terms
for a set of genes were examined using the DAVID
bioinformatics web server [71].
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